CLINICAL IMMUNOLOGY SOCIETY INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

ELIE HADDAD MD PHD

Phone

4142248095

Tax Period

2023-01-01 to 2023-12-31

CLINICAL IMMUNOLOGY SOCIETY INC, founded in 1986, is a community nonprofit in the Diseases & Disorders sector that reported $1.4M in total revenue in fiscal year 2023. Revenue decreased 8% compared to the prior year.

Mission

TO FACILITATE EDUCATION, TRANSLATIONAL RESEARCH AND NOVEL APPROACHES TO THERAPY IN CLINICAL IMMUNOLOGY TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH IMMUNOLOGIC/INFLAMMATORY DISORDERS.

Program Service Accomplishments

Program 1

Expenses: $752,109 Revenue: $325,105

ANNUAL MEETING: TO PROVIDE A STIMULATING AND LIVELY FORUM FOR PRESENTATION AND DISCUSSION OF THE LATEST ADVANCES IN CLINICAL IMMUNOLOGY, INCLUDING PRIMARY IMMUNODEFICIENCIES AND IMMUNE DYSREGULATORY DISEASES, AND RELATED AREAS, INCLUDING MOLECULAR PATHOGENESIS, AND NOVEL THERAPEUTIC APPROACHES.

Program 2

Expenses: $216,014

PRIMARY IMMUNE DEFICIENCY SCHOOL: THE PRIMARY GOAL IS EDUCATION ON THE DIAGNOSIS, PATHOGENESIS, AND TREATMENT OF COMPLEX DISEASES. THE SECONDARY GOALS ARE TO ATTRACT AND DEVELOP FUTURE SCIENTISTS IN ACADEMIC MEDICINE AND TO ENHANCE THE AWARENESS OF CLINICAL IMMUNOLOGY AND ITS IMPORTANCE IN SCIENTIFIC DISCOVERIES AND CLINICAL APPLICATIONS. A THIRD GOAL IS TO STIMULATE FUTURE COLLABORATIONS BETWEEN YOUNG INVESTIGATORS AND EXPERIENCED PHYSICIAN/SCIENTISTS IN THE FIELD.

Program 3

Expenses: $117,773

AIM SCHOOL: IN PARTNERSHIP WITH GRIFOLS, THIS EDUCATIONAL OFFERING FOR THE PIDD COMMUNITY WILL ADVANCE THE EARLY AND MORE ACCURATE DIAGNOSIS OF PIDDS; INFORM AND EDUCATE ABOUT THE INTERSECTION...

AIM SCHOOL: IN PARTNERSHIP WITH GRIFOLS, THIS EDUCATIONAL OFFERING FOR THE PIDD COMMUNITY WILL ADVANCE THE EARLY AND MORE ACCURATE DIAGNOSIS OF PIDDS; INFORM AND EDUCATE ABOUT THE INTERSECTION BETWEEN ACADEMIA, THE CLINIC AND INDUSTRY; AND MENTOR EARLY CAREER IMMUNOLOGISTS TO SUPPORT MOTIVATION AND ADVANCEMENT OF THE PRACTICE OF IMMUNOLOGY AND THE TREATMENT OF PIDDS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $921,800

Program Service Revenue $418,220

Investment Income $51,131

Other Revenue $1,400

TOTAL REVENUE $1,392,551

Expense Breakdown

Grants Paid $250

Salaries & Benefits $0

Fundraising Expenses $165

Program Expenses $1,165,885

Other Expenses $1,375,798

TOTAL EXPENSES $1,376,048

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,392,551	$1,508,029	-0.1%
Expenses	$1,376,048	$1,207,893	+0.1%
Net Income	$16,503	$300,136	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELIE HADDAD MD PHD	PRESIDENT	5.00	Officer Director	$0	$0	$0
REBECCA MARSH MD FCIS	PRESIDENT-ELECT	5.00	Officer Director	$0	$0	$0
SERGIO D ROSENZWEIG MD PHD	PAST PRESIDENT	5.00	Officer Director	$0	$0	$0
DANIEL C ADELMAN MD	SECRETARY/TREASURER	5.00	Officer Director	$0	$0	$0
MEGAN A COOPER MD PHD	DIRECTOR	2.00	Director	$0	$0	$0
MONICA G LAWRENCE MD	DIRECTOR	2.00	Director	$0	$0	$0
LISA R FORBES SATTER MD	DIRECTOR	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,392,551	$1,376,048	$2,434,475	$16,503
2022	$1,508,029	$1,207,893	$2,258,350	$300,136
2021	$831,703	$652,773	$2,456,353	$178,930
2020	$308,490	$439,614	$2,160,113	$-131,124
2019	$1,185,096	$1,167,897	$2,195,463	$17,199
2018	$1,141,912	$1,102,671	$1,956,536	$39,241